Sign In
Buy ARGX
$844.50
+13.71 (+1.65%)
At Close: Aug 04, 2026
Bvf Inc Buys Galapagos NV, Amarin Corp PLC, Aadi Bioscience Inc, Sells Merus NV, argenx SE, ...
02:38am, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: AMRN , KYMR , LXRX , CRNX , RAIN , VSTM , GLPG , AADI , TYRA , PNT , ALPN , ELEV , MRUS , RACA , FBRX , IMVT , CNTA ,
DCF Advisers, LLC Buys Impel NeuroPharma Inc, argenx SE, Apple Inc, Sells Alphabet Inc, , ...
11:38pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: ARGX , AAPL , ALT , EQ , VIR , BABA , IMPL , MRVL , AZN , LIT , TBT , WBA , KIN , ALXN , JNJ , IBM , KSS , KWEB ,
argenx to Present at Upcoming Investor Conferences
01:00am, Wednesday, 10'th Nov 2021
November 10, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and canc
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q3 2021 Results - Earnings Call Transcript
06:44pm, Thursday, 28'th Oct 2021
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q3 2021 Results - Earnings Call Transcript
argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021
01:00am, Thursday, 21'st Oct 2021
October 21 , 202 1 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and can
argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings
01:00am, Friday, 08'th Oct 2021
Breda, the Netherlands – October 8 , 2021 – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and c
argenx to Present at Upcoming Investor Conferences
01:00am, Friday, 03'rd Sep 2021
September 3, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and canc
argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in Generalized Myasthenia Gravis
01:00am, Wednesday, 25'th Aug 2021
Breda, the Netherlands – August 2 5 , 2021 – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and
argenx: R&D Day Goes Unnoticed
11:22am, Monday, 23'rd Aug 2021
argenx: R&D Day Goes Unnoticed
argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference
01:00am, Wednesday, 04'th Aug 2021
August 4, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer,
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q2 2021 Results - Earnings Call Transcript
04:31am, Sunday, 01'st Aug 2021
argenx SE (ARGX) CEO Tim Van Hauwermeiren on Q2 2021 Results - Earnings Call Transcript
Recap: argenx Q2 Earnings
07:24am, Thursday, 29'th Jul 2021
Shares of argenx (NASDAQ:ARGX) decreased 4.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 162.86% over the past year to $1.98, which may not
argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update
01:00am, Thursday, 29'th Jul 2021
- Completion of enrollment expected by year-end for ADAPT-SC and ADVANCE (IV) trials of efgartigimod; topline data for both trials expected in first half of 2022
argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021
01:00am, Thursday, 22'nd Jul 2021
July 22, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer,
argenx to Host Virtual R&D Day on July 20, 2021
01:00am, Wednesday, 14'th Jul 2021
July 14, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer,
